The Alzheimer's Disease Neuroimaging Initiative (ADNI)

MRI methods

Clifford R. Jack, Matt A. Bernstein, Nick C. Fox, Paul Thompson, Gene E Alexander, Danielle Harvey, Bret Borowski, Paula J. Britson, Jennifer L. Whitwell, Chadwick Ward, Anders M. Dale, Joel P. Felmlee, Jeffrey L. Gunter, Derek L G Hill, Ron Killiany, Norbert Schuff, Sabrina Fox-Bosetti, Chen Lin, Colin Studholme, Charles S. DeCarli & 15 others Gunnar Krueger, Heidi A. Ward, Gregory J. Metzger, Katherine T. Scott, Richard Mallozzi, Daniel Blezek, Joshua Levy, Josef P. Debbins, Adam S. Fleisher, Marilyn Albert, Robert Green, George Bartzokis, Gary Glover, John Mugler, Michael W. Weiner

Research output: Contribution to journalArticle

1212 Citations (Scopus)

Abstract

The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquiredat multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications thatguided protocol development. A major effort was devoted toevaluating 3D T1-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B1-calibration scans when applicable; and an axial proton density-T2 dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.

Original languageEnglish (US)
Pages (from-to)685-691
Number of pages7
JournalJournal of Magnetic Resonance Imaging
Volume27
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Neuroimaging
Alzheimer Disease
Magnetic Resonance Imaging
Fluorodeoxyglucose F18
Psychometrics
Positron-Emission Tomography
Calibration
Observational Studies
Sequence Analysis
Cerebrospinal Fluid
Protons
Biomarkers
Clinical Trials
Urine
Pathology
Serum

Keywords

  • Alzheimer's disease
  • Clinical trials
  • Imaging methods
  • Imaging standardization
  • MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G. E., Harvey, D., ... Weiner, M. W. (2008). The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging, 27(4), 685-691. https://doi.org/10.1002/jmri.21049

The Alzheimer's Disease Neuroimaging Initiative (ADNI) : MRI methods. / Jack, Clifford R.; Bernstein, Matt A.; Fox, Nick C.; Thompson, Paul; Alexander, Gene E; Harvey, Danielle; Borowski, Bret; Britson, Paula J.; Whitwell, Jennifer L.; Ward, Chadwick; Dale, Anders M.; Felmlee, Joel P.; Gunter, Jeffrey L.; Hill, Derek L G; Killiany, Ron; Schuff, Norbert; Fox-Bosetti, Sabrina; Lin, Chen; Studholme, Colin; DeCarli, Charles S.; Krueger, Gunnar; Ward, Heidi A.; Metzger, Gregory J.; Scott, Katherine T.; Mallozzi, Richard; Blezek, Daniel; Levy, Joshua; Debbins, Josef P.; Fleisher, Adam S.; Albert, Marilyn; Green, Robert; Bartzokis, George; Glover, Gary; Mugler, John; Weiner, Michael W.

In: Journal of Magnetic Resonance Imaging, Vol. 27, No. 4, 04.2008, p. 685-691.

Research output: Contribution to journalArticle

Jack, CR, Bernstein, MA, Fox, NC, Thompson, P, Alexander, GE, Harvey, D, Borowski, B, Britson, PJ, Whitwell, JL, Ward, C, Dale, AM, Felmlee, JP, Gunter, JL, Hill, DLG, Killiany, R, Schuff, N, Fox-Bosetti, S, Lin, C, Studholme, C, DeCarli, CS, Krueger, G, Ward, HA, Metzger, GJ, Scott, KT, Mallozzi, R, Blezek, D, Levy, J, Debbins, JP, Fleisher, AS, Albert, M, Green, R, Bartzokis, G, Glover, G, Mugler, J & Weiner, MW 2008, 'The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods', Journal of Magnetic Resonance Imaging, vol. 27, no. 4, pp. 685-691. https://doi.org/10.1002/jmri.21049
Jack, Clifford R. ; Bernstein, Matt A. ; Fox, Nick C. ; Thompson, Paul ; Alexander, Gene E ; Harvey, Danielle ; Borowski, Bret ; Britson, Paula J. ; Whitwell, Jennifer L. ; Ward, Chadwick ; Dale, Anders M. ; Felmlee, Joel P. ; Gunter, Jeffrey L. ; Hill, Derek L G ; Killiany, Ron ; Schuff, Norbert ; Fox-Bosetti, Sabrina ; Lin, Chen ; Studholme, Colin ; DeCarli, Charles S. ; Krueger, Gunnar ; Ward, Heidi A. ; Metzger, Gregory J. ; Scott, Katherine T. ; Mallozzi, Richard ; Blezek, Daniel ; Levy, Joshua ; Debbins, Josef P. ; Fleisher, Adam S. ; Albert, Marilyn ; Green, Robert ; Bartzokis, George ; Glover, Gary ; Mugler, John ; Weiner, Michael W. / The Alzheimer's Disease Neuroimaging Initiative (ADNI) : MRI methods. In: Journal of Magnetic Resonance Imaging. 2008 ; Vol. 27, No. 4. pp. 685-691.
@article{df828179612e4360bc29306cbb55e6be,
title = "The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods",
abstract = "The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquiredat multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications thatguided protocol development. A major effort was devoted toevaluating 3D T1-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B1-calibration scans when applicable; and an axial proton density-T2 dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.",
keywords = "Alzheimer's disease, Clinical trials, Imaging methods, Imaging standardization, MRI",
author = "Jack, {Clifford R.} and Bernstein, {Matt A.} and Fox, {Nick C.} and Paul Thompson and Alexander, {Gene E} and Danielle Harvey and Bret Borowski and Britson, {Paula J.} and Whitwell, {Jennifer L.} and Chadwick Ward and Dale, {Anders M.} and Felmlee, {Joel P.} and Gunter, {Jeffrey L.} and Hill, {Derek L G} and Ron Killiany and Norbert Schuff and Sabrina Fox-Bosetti and Chen Lin and Colin Studholme and DeCarli, {Charles S.} and Gunnar Krueger and Ward, {Heidi A.} and Metzger, {Gregory J.} and Scott, {Katherine T.} and Richard Mallozzi and Daniel Blezek and Joshua Levy and Debbins, {Josef P.} and Fleisher, {Adam S.} and Marilyn Albert and Robert Green and George Bartzokis and Gary Glover and John Mugler and Weiner, {Michael W.}",
year = "2008",
month = "4",
doi = "10.1002/jmri.21049",
language = "English (US)",
volume = "27",
pages = "685--691",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - The Alzheimer's Disease Neuroimaging Initiative (ADNI)

T2 - MRI methods

AU - Jack, Clifford R.

AU - Bernstein, Matt A.

AU - Fox, Nick C.

AU - Thompson, Paul

AU - Alexander, Gene E

AU - Harvey, Danielle

AU - Borowski, Bret

AU - Britson, Paula J.

AU - Whitwell, Jennifer L.

AU - Ward, Chadwick

AU - Dale, Anders M.

AU - Felmlee, Joel P.

AU - Gunter, Jeffrey L.

AU - Hill, Derek L G

AU - Killiany, Ron

AU - Schuff, Norbert

AU - Fox-Bosetti, Sabrina

AU - Lin, Chen

AU - Studholme, Colin

AU - DeCarli, Charles S.

AU - Krueger, Gunnar

AU - Ward, Heidi A.

AU - Metzger, Gregory J.

AU - Scott, Katherine T.

AU - Mallozzi, Richard

AU - Blezek, Daniel

AU - Levy, Joshua

AU - Debbins, Josef P.

AU - Fleisher, Adam S.

AU - Albert, Marilyn

AU - Green, Robert

AU - Bartzokis, George

AU - Glover, Gary

AU - Mugler, John

AU - Weiner, Michael W.

PY - 2008/4

Y1 - 2008/4

N2 - The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquiredat multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications thatguided protocol development. A major effort was devoted toevaluating 3D T1-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B1-calibration scans when applicable; and an axial proton density-T2 dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.

AB - The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquiredat multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications thatguided protocol development. A major effort was devoted toevaluating 3D T1-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B1-calibration scans when applicable; and an axial proton density-T2 dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.

KW - Alzheimer's disease

KW - Clinical trials

KW - Imaging methods

KW - Imaging standardization

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=41949137974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949137974&partnerID=8YFLogxK

U2 - 10.1002/jmri.21049

DO - 10.1002/jmri.21049

M3 - Article

VL - 27

SP - 685

EP - 691

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 4

ER -